Skip to content
OpenCapital
Get started

Sabra Healthcare SBRA Cash disbursed for acquisitions

Cash disbursed for acquisitions at other companies

Welltower logo
WelltowerWELL
——

Other financials

Income statement

See full
Revenue$221.8M+20.8%
Net income$40.9M+1.4%
EPS (diluted)$0.16-5.9%

Balance sheet

See full
Cash & equivalents$116.5M+414%
Total debt$7.3M-9.6%
Total equity$2.8B+3.1%
Total assets$5.6B+6.8%

Cash flow

See full
Operating cash flow$98.4M+22.5%

Valuation

See full
Market cap$4.57B+16.7%

Profitability

See full
Net margin19.2%-0.3pp

Returns & leverage

See full
Return on equity5.7%+0.5pp
Debt / equity0×0.0×

Where this comes from

Reported directly by Sabra Healthcare in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquireRealEstate.

The official record: Sabra Healthcare’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Sabra Healthcare's cash disbursed for acquisitions.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Sabra Healthcare's cash disbursed for acquisitions?
Sabra Healthcare (SBRA) reported cash disbursed for acquisitions of $96.1M in Q1 2026.
How has Sabra Healthcare's cash disbursed for acquisitions changed year-over-year?
Sabra Healthcare's cash disbursed for acquisitions increased by 1123.6% year-over-year, from $7.85M to $96.1M.
What is the long-term trend for Sabra Healthcare's cash disbursed for acquisitions?
Over 3 years (2021 to 2025), Sabra Healthcare's cash disbursed for acquisitions has grown at a 65.8% compound annual growth rate (CAGR), from $99.45M to $452.93M.